Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.

Authors:
Han X; Gong C; Yang Q; Zheng K; Wang Z and 1 more

Journal:
Int J Nanomedicine

Publication Year: 2024

DOI:
10.2147/IJN.S442877

PMCID:
PMC10802790

PMID:
38260239

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Nanomedicine

Abbreviation: Int J Nanomedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nanotechnology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to P…
Sekita A; Unterweger H; Berg S and 11 more (2024) - Transparency Score: 3/6
Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.
Xiang D; Zhou L; Yang R and 5 more (2024) - Transparency Score: 3/6
Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nan…
Dong Z; Zhang X; Zhang Q and 4 more (2024) - Transparency Score: 3/6
Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression.
Wang M; Lan S; Zhang W and 7 more (2024) - Transparency Score: 3/6
Anticipation and Verification of Dendrobium-Derived Nanovesicles for Skin Wound Healing Targets, Pr…
Tu J; Jiang F; Fang J and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors report no conflicts of interest in this work."

Evidence found in paper:

"This study was supported by the Shanghai Natural Science Foundation (23ZR1453400)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025